Femasys Stock Investor Sentiment

FEMY Stock  USD 1.60  0.03  1.91%   
Slightly above 63% of all Femasys' investors are looking to take a long position. The analysis of overall sentiment of trading Femasys stock suggests that some investors are interested at this time. Femasys' investing sentiment can be driven by a variety of factors including economic data, Femasys' earnings reports, geopolitical events, and overall market trends.

Comfort Level 63

 Interested

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Femasys' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Femasys.

Femasys Historical Sentiment

Although Femasys' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Femasys, such as negative comments on social media and news outlets, may cause fear in the market and push Femasys' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Femasys.
  

Femasys Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Femasys can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over six months ago at news.google.com         
Femasys Releases Updated Corporate Presentation Online - TipRanks
Google News at Macroaxis
over six months ago at news.google.com         
Femasys gains European and Canadian approval for FemVue MINI - Investing.com
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters
Yahoo News
over six months ago at news.google.com         
Femasys Inc. at August 20th Virtual Investor Summit Microcap Event - StockTitan
Google News at Macroaxis
over six months ago at news.google.com         
Chardan Capital Lowers Femasys Price Target to 10.00 - Defense World
Google News at Macroaxis
over six months ago at news.google.com         
Femasys price target lowered to 10 from 12 at Chardan - TipRanks
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Femasys Second Quarter 2024 Earnings Misses Expectations
Yahoo News
over six months ago at seekingalpha.com         
Femasys reports Q2 results
seekingalpha News
over six months ago at investorplace.com         
FEMY Stock Earnings Femasys Misses EPS, Misses Revenue for Q2 2024
sbwire news
over six months ago at finance.yahoo.com         
Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate Update
Yahoo News
over six months ago at zacks.com         
Omega Therapeutics, Inc. Reports Q2 Loss, Tops Revenue Estimates
zacks News
over six months ago at zacks.com         
Arcturus Therapeutics Reports Q2 Loss, Tops Revenue Estimates
zacks News
over six months ago at news.google.com         
Femasys Inc. Sees Significant Increase in Short Interest - American Banking and Market News
Google News at Macroaxis
over six months ago at news.google.com         
Femasys Inc. Sees Significant Increase in Short Interest - American Banking and Market News
Google News at Macroaxis
over six months ago at news.google.com         
Femasys Inc. Short Interest Update - Defense World
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Femasys that are available to investors today. That information is available publicly through Femasys media outlets and privately through word of mouth or via Femasys internal channels. However, regardless of the origin, that massive amount of Femasys data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Femasys news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Femasys relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Femasys' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Femasys alpha.

Femasys Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Acquisition by Dov Elefant of 72045 shares of Femasys at 1.05 subject to Rule 16b-3
01/28/2025
2
Acquisition by Lee-sepsick Kathy of 59849 shares of Femasys at 1.17 subject to Rule 16b-3
01/29/2025
3
Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth Control
01/30/2025
4
Femasys Announces Israeli Regulatory Approvals for FemaSeed for Female Infertility Treatment and Two Diagnostic Devices
02/04/2025
5
Femasys Announces UK Regulatory Approvals for FemaSeed for Female Infertility Treatment and Two Diagnostic Devices
02/11/2025
6
Acquisition by Adams John Q Jr of 108693 shares of Femasys subject to Rule 16b-3
02/21/2025
7
Femasys Announces Peer-Reviewed Publication of Positive Safety a
02/25/2025
8
Femasys Announces FemBloc Delivery System Approval in Europe A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgi...
03/11/2025

Additional Tools for Femasys Stock Analysis

When running Femasys' price analysis, check to measure Femasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Femasys is operating at the current time. Most of Femasys' value examination focuses on studying past and present price action to predict the probability of Femasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Femasys' price. Additionally, you may evaluate how the addition of Femasys to your portfolios can decrease your overall portfolio volatility.